Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

[1]  T. Nishimura,et al.  Enhanced Abdominal Aortic Aneurysm Formation in Thrombin-Activatable Procarboxypeptidase B–Deficient Mice , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[2]  J. Hillebrands,et al.  Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes. , 2008, Microvascular research.

[3]  J. Golledge,et al.  Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. , 2008, European heart journal.

[4]  M. Halks-Miller,et al.  Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice , 2008, Gene Therapy.

[5]  J. Michel,et al.  Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms , 2007, The Journal of pathology.

[6]  Kenneth K. Wu,et al.  Diabetic atherosclerosis mouse models. , 2007, Atherosclerosis.

[7]  J. Liao,et al.  Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells , 2005, Circulation.

[8]  R. Vergona,et al.  Noninvasive measurement of abdominal aortic aneurysms in intact mice by a high-frequency ultrasound imaging system. , 2005, Ultrasound in medicine & biology.

[9]  Konrad Jamrozik,et al.  Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm , 2004, BMJ : British Medical Journal.

[10]  R. Dalman,et al.  Hemodynamic Regulation of CD34+ Cell Localization and Differentiation in Experimental Aneurysms , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[11]  P. Carmeliet,et al.  Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II–Induced Abdominal Aortic Aneurysm , 2003, Circulation research.

[12]  Timothy C Greiner,et al.  Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.

[13]  P. Eriksson,et al.  The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[14]  S. Haffner,et al.  Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. , 2002, Diabetes.

[15]  J. Lindholt,et al.  Plasma levels of plasmin-antiplasmin-complexes are predictive for small abdominal aortic aneurysms expanding to operation-recommendable sizes. , 2001, Journal of vascular surgery.

[16]  H. Lijnen.  Plasmin and Matrix Metalloproteinases in Vascular Remodeling , 2001, Thrombosis and Haemostasis.

[17]  F. Fowkes,et al.  Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial , 2000, The British journal of surgery.

[18]  G. Moneta,et al.  The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. , 2000, Archives of internal medicine.

[19]  A. V. Rij,et al.  Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. , 2000, Journal of vascular surgery.

[20]  S. Haffner,et al.  Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[21]  H. Okumura,et al.  An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. , 1998, American journal of surgery.

[22]  D J Ballard,et al.  Prevalence and Associations of Abdominal Aortic Aneurysm Detected through Screening , 1997, Annals of Internal Medicine.

[23]  W. Pearce,et al.  Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[24]  A. Henney,et al.  The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. , 1993, The Journal of biological chemistry.

[25]  Xiao Man Yang,et al.  Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway. , 2002, Atherosclerosis.

[26]  U. Ikeda,et al.  Activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm. , 1999, American journal of surgery.